172 related articles for article (PubMed ID: 33350734)
21. A Nomogram to Predict Factors Associated with Lymph Node Metastasis in Ductal Carcinoma In Situ with Microinvasion.
Gooch JC; Schnabel F; Chun J; Pirraglia E; Troxel AB; Guth A; Shapiro R; Axelrod D; Roses D
Ann Surg Oncol; 2019 Dec; 26(13):4302-4309. PubMed ID: 31529311
[TBL] [Abstract][Full Text] [Related]
22. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
[TBL] [Abstract][Full Text] [Related]
23. The Demographic Features, Clinicopathological Characteristics and Cancer-specific Outcomes for Patients with Microinvasive Breast Cancer: A SEER Database Analysis.
Wang W; Zhu W; Du F; Luo Y; Xu B
Sci Rep; 2017 Feb; 7():42045. PubMed ID: 28165014
[TBL] [Abstract][Full Text] [Related]
24. Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion?
Flanagan MR; Stempel M; Brogi E; Morrow M; Cody HS
Ann Surg Oncol; 2019 Sep; 26(9):2738-2746. PubMed ID: 31147995
[TBL] [Abstract][Full Text] [Related]
25. DCIS with Microinvasion: Is It In Situ or Invasive Disease?
Champion CD; Ren Y; Thomas SM; Fayanju OM; Rosenberger LH; Greenup RA; Menendez CS; Hwang ES; Plichta JK
Ann Surg Oncol; 2019 Oct; 26(10):3124-3132. PubMed ID: 31342393
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic analysis of a large series of microinvasive breast cancers.
Lillemoe TJ; Tsai ML; Swenson KK; Susnik B; Krueger J; Harris K; Rueth N; Grimm E; Leach JW
Breast J; 2018 Jul; 24(4):574-579. PubMed ID: 29476574
[TBL] [Abstract][Full Text] [Related]
27. Role of Sentinel Lymph Node Biopsy in Microinvasive Breast Cancer.
Fan B; Pardo JA; Serres S; Alapati AC; Szewczyk J; Mele A; James TA
Ann Surg Oncol; 2020 Oct; 27(11):4468-4473. PubMed ID: 32430750
[TBL] [Abstract][Full Text] [Related]
28. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
29. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
Si J; Guo R; Huang N; Xiu B; Zhang Q; Chi W; Wu J
Cancer Med; 2019 Dec; 8(18):7586-7593. PubMed ID: 31660702
[TBL] [Abstract][Full Text] [Related]
30. Clinical and Imaging Characteristics of Contrast-enhanced Mammography and MRI to Distinguish Microinvasive Carcinoma from Ductal Carcinoma In situ.
Hua B; Yang G; An Y; Lou K; Chen J; Quan G; Yuan T
Acad Radiol; 2024 May; ():. PubMed ID: 38734581
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ.
Pang J; Yan Z; Tan QT; Allen JC; Wang M; Lim GH
Clin Breast Cancer; 2024 Jun; 24(4):363-367. PubMed ID: 38458843
[TBL] [Abstract][Full Text] [Related]
32. Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion.
Han S; Qiu F; Han Y; Xu Y; Yin J; Xing F; Bian X; He G
J Appl Clin Med Phys; 2021 Jan; 22(1):293-298. PubMed ID: 33332730
[TBL] [Abstract][Full Text] [Related]
33. Axillary node staging for microinvasive breast cancer: is it justified?
Lyons JM; Stempel M; Van Zee KJ; Cody HS
Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
[TBL] [Abstract][Full Text] [Related]
34. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
[TBL] [Abstract][Full Text] [Related]
35. Ductal carcinoma in situ with microinvasion.
Adamovich TL; Simmons RM
Am J Surg; 2003 Aug; 186(2):112-6. PubMed ID: 12885600
[TBL] [Abstract][Full Text] [Related]
36. Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome.
Vieira CC; Mercado CL; Cangiarella JF; Moy L; Toth HK; Guth AA
Eur J Radiol; 2010 Jan; 73(1):102-7. PubMed ID: 19026501
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.
Wasserberg N; Morgenstern S; Schachter J; Fenig E; Lelcuk S; Gutman H
Arch Surg; 2002 Nov; 137(11):1249-52. PubMed ID: 12413311
[TBL] [Abstract][Full Text] [Related]
38. Lymph node metastasis from ductal carcinoma in situ with microinvasion.
Zavotsky J; Hansen N; Brennan MB; Turner RR; Giuliano AE
Cancer; 1999 Jun; 85(11):2439-43. PubMed ID: 10357415
[TBL] [Abstract][Full Text] [Related]
39. Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion.
Li C; Yang Y; Wang J; Jin K; Yang Z; Yu X; Guo X; Chen X
Cancer Med; 2021 Oct; 10(20):7203-7212. PubMed ID: 34547183
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological Follow-up of Breast DCIS Diagnosed on Biopsies: A Single Institutional Study of 575 Patients.
Yan M; Bomeisl P; Gilmore H; Harbhajanka A
Int J Surg Pathol; 2021 Dec; 29(8):836-843. PubMed ID: 33890815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
